Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche
暂无分享,去创建一个
R. Paus | C. Griffiths | E. Poblet | M. Harries | K. Meyer | I. Chaudhry | Jennifer E Kloepper | Christopher EM Griffiths
[1] J. Shapiro,et al. Somatostatin expression in human hair follicles and its potential role in immune privilege. , 2013, The Journal of investigative dermatology.
[2] Y. Tokura,et al. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. , 2013, Journal of dermatological science.
[3] Liang-Tung Yang,et al. Differential response of epithelial stem cell populations in hair follicles to TGF-β signaling. , 2013, Developmental biology.
[4] C. Craddock,et al. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD. , 2012, Blood.
[5] K. Nylander,et al. Increased levels of COX‐2 in oral lichen planus supports an autoimmune cause of the disease , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] R. Paus,et al. Primary cicatricial alopecias: a U.K. survey , 2012, The British journal of dermatology.
[7] K. Horiuchi,et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin , 2012, Nature Immunology.
[8] J. Dutz,et al. Type 1 IFN‐induced protein MxA and plasmacytoid dendritic cells in lesions of morphea , 2012, Experimental dermatology.
[9] A. Tosti,et al. Treatment options for alopecia: an update, looking to the future , 2012, Expert opinion on pharmacotherapy.
[10] A. Baibergenova,et al. Use of Pioglitazone in Patients with Lichen Planopilaris , 2012, Journal of cutaneous medicine and surgery.
[11] Mayumi Ito,et al. Dissecting the bulge in hair regeneration. , 2012, The Journal of clinical investigation.
[12] J. Sundberg,et al. Increased expression of Cxcr3 and its ligands, Cxcl9, and Cxcl10, during the development of alopecia areata in the mouse , 2012, The Journal of investigative dermatology.
[13] E. Fuchs,et al. Paracrine TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. , 2012, Cell stem cell.
[14] M. Ohyama. Primary cicatricial alopecia: Recent advances in understanding and management , 2012, The Journal of dermatology.
[15] W. Bergfeld,et al. Differential expression of stem cell markers in lichen planopilaris and alopecia areata , 2011, The British journal of dermatology.
[16] C. Ko,et al. Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining , 2011, Journal of cutaneous pathology.
[17] M. Rotondi,et al. The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. , 2011, Current pharmaceutical design.
[18] R. Tirumalae,et al. Histopathology of Scarring Alopecia in Indian Patients , 2011, The American Journal of dermatopathology.
[19] R. Paus,et al. Can the hair follicle become a model for studying selected aspects of human ocular immune privilege? , 2011, Investigative ophthalmology & visual science.
[20] Charles P. Lin,et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche , 2011, Nature.
[21] K. Ranganathan,et al. Oral lichen planus: An update on pathogenesis and treatment , 2011, Journal of oral and maxillofacial pathology : JOMFP.
[22] B. Smoller,et al. Comparison Between Langerhans Cell Concentration in Lichen Planopilaris and Traction Alopecia With Possible Immunologic Implications , 2011, The American Journal of dermatopathology.
[23] F. Watt,et al. The Basement Membrane of Hair Follicle Stem Cells Is a Muscle Cell Niche , 2011, Cell.
[24] J. Tobias,et al. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. , 2011, The Journal of clinical investigation.
[25] J. Shapiro,et al. Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. , 2010, The Journal of investigative dermatology.
[26] R. Paus,et al. The pathogenesis of primary cicatricial alopecias. , 2010, The American journal of pathology.
[27] H. Waldmann. Tolerance: an overview and perspectives , 2010, Nature Reviews Nephrology.
[28] R. Paus,et al. IFN-gamma induces bulge immunoprivilege collapse and may cause epithelial stem cell exhaust , 2010 .
[29] R. Paus,et al. Management of alopecia areata , 2010, BMJ : British Medical Journal.
[30] K. Stenn,et al. Lipids to the top of hair biology. , 2010, The Journal of investigative dermatology.
[31] C. Blanpain,et al. A dominant role of the hair follicle stem cell niche in regulating melanocyte stemness. , 2010, Cell stem cell.
[32] Mohamed El-behi,et al. Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis , 2010, Journal of Neuroimmune Pharmacology.
[33] K. Meyer,et al. Does collapse of immune privilege in the hair‐follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? , 2009, Clinical and experimental dermatology.
[34] Lionel B Ivashkiv,et al. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.
[35] R. Paus,et al. Nonviral In Situ Green Fluorescent Protein Labeling and Culture of Primary, Adult Human Hair Follicle Epithelial Progenitor Cells , 2009, Stem cells.
[36] E. Ingham,et al. Expression of hair follicle stem cells detected by cytokeratin 15 stain: implications for pathogenesis of the scarring process in cutaneous lupus erythematosus , 2009, The British journal of dermatology.
[37] Kevin D Cooper,et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. , 2009, The Journal of investigative dermatology.
[38] Ralf Paus,et al. Scarring alopecia and the PPAR-gamma connection. , 2009, The Journal of investigative dermatology.
[39] A. Tosti,et al. How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia , 2009, The British journal of dermatology.
[40] P. Assouly,et al. Lichen planopilaris: update on diagnosis and treatment. , 2009, Seminars in cutaneous medicine and surgery.
[41] A. Munnich,et al. Stabilization of RNA during laser capture microdissection by performing experiments under argon atmosphere or using ethanol as a solvent in staining solutions. , 2008, RNA.
[42] F. Wojnarowska,et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. , 2008, Archives of dermatology.
[43] R. Paus,et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles , 2008, The British journal of dermatology.
[44] J. Wenzel,et al. An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". , 2008, The Journal of investigative dermatology.
[45] M. Mahalingam,et al. Involvement of the bulge region in primary scarring alopecia , 2008, Journal of cutaneous pathology.
[46] R. Paus,et al. Management of primary cicatricial alopecias: options for treatment , 2008, The British journal of dermatology.
[47] R. Paus,et al. Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche , 2008, Experimental dermatology.
[48] R. Paus,et al. Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. , 2008, The Journal of investigative dermatology.
[49] E. Fuchs,et al. NFATc1 Balances Quiescence and Proliferation of Skin Stem Cells , 2008, Cell.
[50] T. Bieber,et al. CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. , 2007, Journal of the American Academy of Dermatology.
[51] R. Paus,et al. Towards the development of a simplified long‐term organ culture method for human scalp skin and its appendages under serum‐free conditions , 2007, Experimental dermatology.
[52] S. Wahl,et al. TGF‐β: a mobile purveyor of immune privilege , 2006 .
[53] G. Cotsarelis. Epithelial stem cells: a folliculocentric view. , 2006, The Journal of investigative dermatology.
[54] J. Niederkorn. See no evil, hear no evil, do no evil: the lessons of immune privilege , 2006, Nature Immunology.
[55] M. Rosenblum,et al. CD200, a "no danger" signal for hair follicles. , 2006, Journal of dermatological science.
[56] G. Cotsarelis. Gene expression profiling gets to the root of human hair follicle stem cells. , 2005, The Journal of clinical investigation.
[57] Mark C Udey,et al. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. , 2005, The Journal of clinical investigation.
[58] Jane Q. Nguyen,et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis , 2005, Nature Medicine.
[59] H. Kamino,et al. Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype , 2005, Journal of cutaneous pathology.
[60] E. Poblet,et al. Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study , 2005, International journal of dermatology.
[61] J. Shapiro,et al. Update on primary cicatricial alopecias. , 2005, Journal of the American Academy of Dermatology.
[62] P. Arck,et al. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. , 2004, The Journal of investigative dermatology.
[63] Yaping Liu,et al. Capturing and profiling adult hair follicle stem cells , 2004, Nature Biotechnology.
[64] R. Paus,et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. , 2004, The American journal of pathology.
[65] E. Fuchs,et al. Defining the Epithelial Stem Cell Niche in Skin , 2004, Science.
[66] P. Sugerman,et al. The pathogenesis of oral lichen planus. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[67] S. Millar,et al. Towards a molecular understanding of hair loss and its treatment. , 2001, Trends in molecular medicine.
[68] D. Tobin,et al. Patterns of proliferation and apoptosis during murine hair follicle morphogenesis. , 2001, The Journal of investigative dermatology.
[69] D. Tobin,et al. The human hair follicle immune system: cellular composition and immune privilege , 2000, The British journal of dermatology.
[70] R. Paus,et al. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. , 1998, The Journal of investigative dermatology.
[71] S. Gibbs,et al. Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. , 2012, The Journal of investigative dermatology.
[72] T. Bieber,et al. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus. , 2011, The Journal of investigative dermatology.
[73] Robert H. Bell,et al. Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. , 2010, Journal of dermatological science.
[74] T. Bieber,et al. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus , 2008, Archives of Dermatological Research.
[75] A. Bosio,et al. Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. , 2008, The Journal of investigative dermatology.
[76] T. Shiohara,et al. Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells. , 2008, Current directions in autoimmunity.
[77] R. Paus,et al. A 'hairy' privilege. , 2005, Trends in immunology.
[78] J. M. Weitzner. Alopecia areata. , 1990, American family physician.